Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» bremelanotide
bremelanotide
Is sexual desire a medical issue? An experimental drug for women revives an intense debate
Stat
Thu, 06/20/19 - 09:48 am
FDA
female sexual dysfunction
bremelanotide
HSDD
Amag Pharmaceuticals
Palatin's Female Sexual Function Drug Succeeds, Offers Large Upside
Seeking Alpha
Wed, 11/9/16 - 09:51 am
Palatin
female sexual dysfunction
bremelanotide
Key FDA Decisions and Trial Results Expected in October
24/7 Wall St
Thu, 09/8/16 - 09:50 am
FDA
clinical trials
cabozantinib
Cobimetinib
Exelixis
Medivation
Xtandi
Celldex Therapeutics
glemba
Palatin
bremelanotide
CRLX101
Cerulean Pharma
Anthera Pharmaceuticals
NJ biotech firm develops 'female Viagra' for women with low sexual desire
The Star Ledger, NJ
Sun, 04/20/14 - 10:02 am
bremelanotide
Palatin
female sexual dysfunction
Targeting An Untapped Female Sexual Dysfunction Drug Market
Seeking Alpha
Tue, 09/3/13 - 11:23 am
female sexual dysfunction
Osphena
Shionogi
flibanserin
Sprout Pharmaceuticals
bremelanotide
Palatin
Femprox
Apricus Biosciences
Palatin Investors Prepared For The Long Haul With Another FSD Drug
Seeking Alpha
Wed, 11/14/12 - 12:25 pm
Palatin
FSD
bremelanotide